Simple precipitation-based method for the screening of type III hyperlipoproteinemia

Clinical Chemistry

Volumn 45, Issue 6 I, 1999, Pages 909-911

  Nauck, Matthias ^a   Glatt, Lioba ^a   März, Winfried ^a   Feussner, Giso ^b   Wieland, Heinrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; DIFFERENTIAL DIAGNOSIS; FAMILIAL DISEASE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SCREENING TEST;

EID: 0033029746     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.6.909     Document Type: Article

References (20)

1. Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Intern Med 1975;82:158-74.
2. Brewer HB Jr, Zech LA, Gregg RW, Schwart D, Schäfer J. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology and treatment. Ann Intern Med 1983;98:623-40.
3. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
4. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988:8:1-21.
5. Weisgraber KH, Rall SC, Mahley RW, Human E apoprotein heterogeneity. Cysteine arginine interchanges in the amino acid sequence of the apo E isoforms. J Biol Chem 1981;256:9077-83.
6. Schneider WJ, Kovanen PI, Brown MS, Goldstein JL, Utermann G, Weber W, et al. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotcin receptors of human fibroblasts and membranes from liver and adrenals of rats, rabbits and cows. J Clin Investig 1981;68:1075-85.
7. Lalazar A, Welsgraber KH, Rall SC, Giladi H Jr, Innerarity TL, Lavanon AZ, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem 1988;263:3542-5.
8. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1991;269:604-7.
9. Hazzard WR, Porte D, Bierman EL. Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type III hyperlipoproteinemia). Metabolism 1972;21:1009-19.
10. Fredrickson DS, Morganroth J, Levy RI. Type III hyperlipoproteinemia. An analysis of two contemporary definitions. Ann Intern Med 1975:82:150-7.
11. März W, Feussner G, Siekmeier R, Donnerhak B, Schaaf L, Ruzicka V, Gross W, Apolipoprotein E to B ratio, a marker for type III hyperlipoproteinemia. Eur J Clin Chem Clin Biochem 1993;31:743-7.
12. National Heart and Lung Institute. Manual of laboratory operation. Lipid Research Clinics Program. DHEW No, (NIH) 75-628. Bethesda, MD: National Heart and Lung Institute, 1974:1-74.
13. Wanner C, Hörl WH, Luley C, Wieland H. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 1991;39:754-9.
14. Luley C, Baumstark MW, Wieland H. Rapid apolipoprotein E phenotyping by immunofixation in agarose. J Lipid Res 1991;5:880-3.
15. Luley CH, Haas B, Būhrer B, Wieland H. Improvement of apolipoprotein E phenotyping by isoelectric focusing/immunofixation [Letter]. Clin Chem 1992;38:168.
16. Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample size. Part II. J Clin Chem Biochem 1984;22:431-45.
17. Armstrong V, Seidel D, Evaluation of a commercial kit for the determination of LDL cholesterol in serum based on precipitation of LDL with dextran sulfate. Ärzt Lab 1985;31:325-33.
18. SieKmeier R, März W, Gross W. Precipitation of LDL with sulfated polyanions: three methods compared. Clin Chim Acta 1988;177:221-30.
19. Nauck M, Friedrich I, Wieland H. Measurement of LDL and VLDL cholesterol with precipitation techniques. A comparison with the ultracentrifugation method. Clin Lab 1994;40:167-76.
20. Nauck M, März W, Wioland H. Adding albumin normalizes electrophoretic mobility of lipoproteins in sera with high concentrations of free fatty acids Clin Chem 1996;42:1283-5.